"Cancersensor" Chemotherapy
NCT01693861 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2025-12-10
Summary
Observational, non randomized study aimed at measuring the effect of chemotherapy in the urinary concentrations of physiological modified nucleosides in 30 patients with metastatic colorectal cancer.
Conditions
Sponsors & Collaborators
-
Institut National de la Santé Et de la Recherche Médicale, France
lead OTHER_GOV
Principal Investigators
-
Francis Lévi, MD PhD · INSERM CNRS AP-HP Université Paris Sud
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2015-02-28
- Completion
- 2015-02-28
Countries
- France
Study Locations
More Related Trials
-
Chemotherapy With DNA Damaging Agents In Colorectal Cancer
NCT01456923 ·Status: COMPLETED ·Phase: PHASE1
-
Organoids-on-a-chip for Colorectal Cancer and in Vitro Screening of Chemotherapeutic Drugs
NCT04996355 ·Status: UNKNOWN
-
Effect of Silymarin in Metastatic Colorectal Cancer Patients
NCT05631041 ·Status: RECRUITING ·Phase: PHASE3
-
Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation
NCT04163289 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer
NCT02688023 ·Status: UNKNOWN ·Phase: PHASE2
-
Evolution of Proteomic Profiles of Intestinal Microbiota in Patients With Locally Advanced or Metastatic Urothelial Carcinomas
NCT04566029 ·Status: COMPLETED
-
Safety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal Cancer
NCT07076823 ·Status: RECRUITING ·Phase: PHASE1
-
Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal Cancer
NCT02032485 ·Status: COMPLETED ·Phase: PHASE2
-
High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer
NCT03008499 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Preoperative Chemoradiotherapy on Exercise Capacity as Measured by Cardiopulmonary Exercise Testing
NCT00833508 ·Status: COMPLETED ·Phase: NA
-
A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA
NCT03679039 ·Status: UNKNOWN
-
Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting
NCT06792149 ·Status: RECRUITING
-
Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms
NCT04363983 ·Status: RECRUITING ·Phase: NA
-
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
NCT07319364 ·Status: RECRUITING ·Phase: PHASE1
-
Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors
NCT03063918 ·Status: COMPLETED ·Phase: NA
-
Prospective Observational Study of a Precision Medicine Approach in Patients With Advanced Cancer
NCT05926284 ·Status: RECRUITING
-
Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy
NCT00414232 ·Status: COMPLETED
-
Association Between the Composition of the Intestinal Microbiota and Tumor Response in Locally Advanced Rectal Cancer
NCT06181201 ·Status: TERMINATED
-
Non-interventional Observational Study of Helical Tomotherapy for Oligometastatic Colorectal Cancer
NCT00807313 ·Status: COMPLETED
-
Molecular Profiling to Improve Outcome of Patients in Cancer. A Pilot Study
NCT03546127 ·Status: COMPLETED
-
Effect of the Use of Symbiotics in Patients With Colon Cancer
NCT04874883 ·Status: UNKNOWN ·Phase: PHASE4
-
Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China
NCT06717178 ·Status: RECRUITING
-
Hepatopulmonary Radio-sterilization With Immunotherapy
NCT06053996 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Extent of Lymph Node Dissection for Advanced Right-Sided Colon Cance
NCT06986538 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer
NCT06858956 ·Status: NOT_YET_RECRUITING